Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Sydney Brenner on the State of Science | Main | More Good PD-1 News in Cancer »

March 4, 2014

Novartis's Stealthy Headcount Reductions

Email This Entry

Posted by Derek

Novartis has always been very, very quiet about their re-orgs and layoffs, to the point that when I and others write about them, we get hits from people at Novartis trying to find out what's going on. John Carroll at FierceBiotech has experience this as well, and he now has this story, from a reporter at the Swiss Tages-Anzeiger newspaper, that says that the company has actually eliminated between 3,000 and 4,000 jobs since last fall.

That comes to about a thousand in Europe (500 of them in Basel), 760 in the US (mostly in the sales force), and 400 during the closure of Horsham in the UK. My impression is that many of the others represent various manufacturing sites. Congratulations to the Zürich newspaper's Andreas Möckli for digging all this out - it could not have been easy. Here's my translation of the introductory paragraph:

It's a proven pattern for the drug company - Novartis is built up, worldwide, from various sites, but the whole extent of its actions are never communicated. While other companies inside (and outside) the industry announce their staff reductions with concrete numbers, Novartis is often content just confirming local media reports. At its Group level, the company has never announced any job cuts, even though jobs are lost in different locations. . .

Comments (6) + TrackBacks (0) | Category: Business and Markets


COMMENTS

1. anchor on March 4, 2014 9:03 AM writes...

Major pharmaceutical companies including those in the USA are eliminating jobs at will in a surreptitious manner! Nothing new about that!

Permalink to Comment

2. anchor on March 4, 2014 9:04 AM writes...

Major pharmaceutical companies including those in the USA are eliminating jobs at will in a surreptitious manner! Nothing new about that!

Permalink to Comment

3. anonymous on March 4, 2014 10:31 AM writes...

"760 in the US (mostly in the sales force)"

I thought I read cancer discovery in Emeryville was hit last fall

Permalink to Comment

4. Quintus on March 4, 2014 11:14 AM writes...

We got any info. about the company from the local press and radio, hours maybe even a day before we were told anything. They don't give a damm.

Permalink to Comment

5. Anonymous on March 4, 2014 1:21 PM writes...

Small correction to your translation: It does not say "Novartis is built up from various sites worldwide" but "Novartis cut jobs at various sites worldwide" in the German original ("abbauen" vs. "aufbauen" or "aufgebaut sein").

Permalink to Comment

6. Anonymous on March 5, 2014 9:23 PM writes...

If anything is left at Novartis Emeryville in two years it would be a surprise

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Chemistry Class For the "Food Babe"?
Thalidomide, Bound to Its Target
TDP-43 and Alzheimer's
Reversal of Type II Diabetes May Be Possible
An Easy Way to Make Cyclic Peptides
What Structures Have Turned on You?
K. C. Nicolaou on Drug Discovery
The Prospects of an Academic Job